Jason Bouvier
Stock Analyst at Scotiabank
(1.57)
# 3,161
Out of 4,711 analysts
9
Total ratings
33.33%
Success rate
1.94%
Average return
Main Sectors:
Stocks Rated by Jason Bouvier
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
OVV Ovintiv | Maintains: Sector Outperform | $50 → $53 | $37.78 | +40.29% | 3 | Nov 18, 2024 | |
IMO Imperial Oil | Downgrades: Sector Perform | $110 | $61.73 | +78.20% | 2 | Sep 25, 2024 | |
SU Suncor Energy | Maintains: Sector Perform | $61 → $60 | $34.50 | +73.91% | 1 | Jul 12, 2024 | |
CVE Cenovus Energy | Maintains: Sector Outperform | $35 → $34 | $14.42 | +135.78% | 1 | Jul 12, 2024 | |
CNQ Canadian Natural Resources | Maintains: Sector Perform | $114 → $57 | $29.58 | +92.70% | 1 | Jun 11, 2024 | |
IKNA Ikena Oncology | Initiates: Buy | n/a | $1.55 | - | 1 | Apr 20, 2021 |
Ovintiv
Nov 18, 2024
Maintains: Sector Outperform
Price Target: $50 → $53
Current: $37.78
Upside: +40.29%
Imperial Oil
Sep 25, 2024
Downgrades: Sector Perform
Price Target: $110
Current: $61.73
Upside: +78.20%
Suncor Energy
Jul 12, 2024
Maintains: Sector Perform
Price Target: $61 → $60
Current: $34.50
Upside: +73.91%
Cenovus Energy
Jul 12, 2024
Maintains: Sector Outperform
Price Target: $35 → $34
Current: $14.42
Upside: +135.78%
Canadian Natural Resources
Jun 11, 2024
Maintains: Sector Perform
Price Target: $114 → $57
Current: $29.58
Upside: +92.70%
Ikena Oncology
Apr 20, 2021
Initiates: Buy
Price Target: n/a
Current: $1.55
Upside: -